Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Ocular Therapeutixâ„¢ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OCUL : 8.50 (+0.59%)
Ocular Therapeutix, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference in January 2025

Ocular Therapeutix, Inc. will present at the J.P. Morgan Healthcare Conference on January 13, 2025, in San Francisco.Quiver AI SummaryOcular Therapeutix, Inc. announced that it will present at the 43rd...

OCUL : 8.50 (+0.59%)
Ocular Therapeutixâ„¢ to Present at the 43rd Annual J.P. Morgan Healthcare Conference

OCUL : 8.50 (+0.59%)
Ocular Therapeutix Initiates First Registrational Trial SOL-1 for AXPAXLIâ„¢ in Wet AMD with Topline Data Expected Q4 2025

Ocular Therapeutix announced significant progress in the SOL-1 trial for AXPAXLIâ„¢, aimed at treating wet AMD.Quiver AI SummaryOcular Therapeutix, Inc. has announced that it has successfully randomized...

OCUL : 8.50 (+0.59%)
Ocular Therapeutixâ„¢ Announces More Than 300 Subjects Randomized in SOL-1

OCUL : 8.50 (+0.59%)
Insider Sale: Chief Scientific Officer of $OCUL (OCUL) Sells 2,948 Shares

Jeffrey S. Heier, the Chief Scientific Officer of $OCUL ($OCUL), sold 2,948 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

OCUL : 8.50 (+0.59%)
Ocular Therapeutix, Inc. to Participate in December Investor and Scientific Conferences

Ocular Therapeutix will participate in December conferences highlighting advancements in retinal disease therapies and ongoing clinical trials.Quiver AI SummaryOcular Therapeutix, Inc., a biopharmaceutical...

OCUL : 8.50 (+0.59%)
Ocular Therapeutixâ„¢ to Participate in December Investor and Scientific Conferences

OCUL : 8.50 (+0.59%)
Ocular Therapeutix: Q3 Earnings Snapshot

Ocular Therapeutix: Q3 Earnings Snapshot

OCUL : 8.50 (+0.59%)
Ocular Therapeutixâ„¢ Reports Third Quarter 2024 Results and Business Highlights

OCUL : 8.50 (+0.59%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar